Arterial stiffness in diabetes mellitus.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing observational and mechanistic literature without quantitative meta-analysis
PubMed 25558032 · doi:10.1016/j.atherosclerosis.2014.12.023
What was done
The authors conducted a systematic literature search to review current evidence on arterial stiffness across pre-diabetes, metabolic syndrome, and established diabetes mellitus, focusing on associations with diabetic complications and underlying mechanisms such as advanced glycation end-products and nitric oxide dysregulation.
What was found
The abstract reports qualitative conclusions without numerical data or effect sizes. Reviewed evidence indicates that arterial stiffness is elevated in metabolic syndrome and impaired glucose tolerance prior to overt diabetes, correlates with the progression of diabetic nephropathy, retinopathy, and neuropathy, and may predict incident diabetes mellitus.
Why it matters
This review synthesizes evidence showing that arterial stiffening develops early in the dysglycemic spectrum and tracks with microvascular damage, highlighting arterial stiffness as a potential prognostic marker in diabetes.
Limits
No quantitative findings, meta-analytic pooling, study counts, or participant numbers are reported in the abstract. Causal links between arterial stiffness and diabetes pathogenesis remain unestablished, and whether therapeutic interventions targeting arterial stiffness improve clinical outcomes remains unproven.
Cited by
- supports Chronically elevated blood glucose drives protein glycation, oxidative stress, and vascular inflammation, damaging blood vessels in the kidneys, retina, feet, coronary arteries, and carotid arteries.